Surgi-Vision To Pursue AAA Indication For Intercept-Vascular MRI Coil
This article was originally published in The Gray Sheet
Executive Summary
Surgi-Vision plans to pursue expanded indications for its Intercept-Vascular peripheral imaging guidewire to diagnose abdominal aortic aneurysms and to assist in atrial arrhythmia ablation procedures.
You may also be interested in...
Surgi-Vision/GE Medical Will Market Internal MRI Coils In Early 2001
Surgi-Vision, Inc. plans to market internal magnetic resonance imaging (MRI) coils in the first quarter of 2001, following FDA 510(k) clearance of a MRI coil for insertion in the female urethra (SVUC) Oct. 11.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.